Rifabutin-induced cystoid macular oedema.
Rifabutin is a semi-synthetic antimycobacterial agent mainly used in the treatment of Mycobacterium avium-complex (MAC) in AIDS patients. Rifabutin-induced anterior uveitis has been reported previously. We report the case of a rifabutin-induced cystoid macular oedema (CMO) in an immunocompetent patient with pulmonary MAC infection. As far as we know, CMO secondary to rifabutin therapy has not been described previously.
Vaudaux
J D
JD
Jules Gonin Eye Hospital, University Department of Ophthalmology, Avenue de France 15, 1004 Lausanne, Switzerland.
Guex-Crosier
Y
Y
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008269:Macular Edema / Q000139:chemically induced* / Q000175:diagnosis; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy; D017828:Rifabutin / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D017828:Rifabutin